Phase 4 N=189 Best Management of Muscle Relaxation- Objective Monitoring
Residual Paralysis, Post Anesthesia
Primary: Incidence of Postoperative Residual Neuromuscular Blockade at Time of Extubation — 0 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=36 Mercury Metabolism by Bacteria in Humans
Mercury--Toxicology
Primary: Mercury Elimination Rate Before Pre-biotic — 48.5 days
N/A N=824 Mobile Strategies for Women's and Children's Health: Optimizing Adherence and Efficacy of PMTCT/ART
mHealth · PMTCT · Adherence, Medication
Primary: Maternal Virologic Failure — 90; 119; 99 VL measurements
N/A N=228 Multi-site Anesthesia Randomized Controlled STudy of End Tidal Control Compared to Conventional Anesthesia Results
Et Control Performance in Adult Population Surgery
Primary: Percent Duration Without Large Deviation of End-Tidal Anesthetic Agent (EtAA) Based on Extraction Algorithm (ALG) — 91.7; 80.8 percent duration — p=<.001
N/A N=145 Bipolar Ventricular Tachycardia (VT) Study
Ventricular Tachycardia
Primary: Number of Participants Achieving Freedom From Recurrent Ventricular Tachycardia (VT) — 16; 29 Participants
Phase 4 N=11 Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes
Type 2 Diabetes · Hypertension
Primary: Change in Blood Pressure From Baseline to 6 Weeks Measured by ABPM — -10.72; 1.94; -3.34; 1.56 mmHg
N/A N=155 Immediate Postpartum Contraceptive Implant Placement and Breastfeeding Success in Women at Risk for Low Milk Supply: A Non-inferiority Trial
Contraception · Breastfeeding · Postpartum Contraception
Primary: Number of Participants Breastfeeding at 6 Months — 6; 4; 6 Participants
N/A N=237 Default Dosing Settings for Opioid Prescriptions to Adolescents and Young Adults After Tonsillectomy
Tonsillectomy
Primary: Number of Doses in the Initial Discharge Opioid Prescription — 22.3; 16.1; 33.7; 30.4 Doses
N/A N=94 A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo
Healthy
Primary: Number of Participants That Develop Acute Respiratory Illnesses When Using Halo vs Placebo — 2; 4 participants
Phase 2 N=46 Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders
Fetal Alcohol Spectrum Disorders
Primary: Elicited Imitation Memory Task - Short Delay Memory Measure: 6 Months — 0.252; 0.183 change in percentage correct
N/A N=223 Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee
Osteoarthritis of Knee
Primary: Western Ontario and McMaster Universities Arthritis (WOMAC) Composite Score: Percent Change From Baseline to Week 12. — 85.75; 69.97 percentage of change
Phase 3 N=220 Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)
Cytomegalovirus Infection
Primary: Percentage of Participants With Clinically Significant CMV Infection From Week 14 (~100 Days) Post-transplant Through Week 28 (~200 Days) Post-transplant — 2.8; 18.9…
Phase 3 N=333 Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)
Attention Deficit Hyperactivity Disorder (ADHD)
Primary: Efficacy and Safety of SPN-810 on the Frequency of Impulsive Aggression (IA) Measured by the Impulsive Aggression Diary — -48.16; -47.88; -58.56 percent change of IA…
Phase 2 N=28 Pomalidomide for Kaposi Sarcoma in People With or Without HIV
Kaposi Sarcoma · Sarcoma, Kaposi
Primary: Number of Participants With Grades 1-4 Adverse Events That Are Possibly, Probably, and/or Definitely Attributed to Pomalidomide — 21; 10; 1; 0 Participants
Phase 2 N=147 A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Primary: The Change From Baseline in Forced Vital Capacity (FVC) at 12 Weeks — -77.70; 2.72; -95.62; 6.10 Milliliter